• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泰国无并发症恶性疟原虫疟疾患者的抗疟药物耐药性分子标记物多态性与青蒿琥酯-甲氟喹联合治疗的关系。

Polymorphisms of molecular markers of antimalarial drug resistance and relationship with artesunate-mefloquine combination therapy in patients with uncomplicated Plasmodium falciparum malaria in Thailand.

机构信息

Thailand Center of Excellence on Drug Discovery and Development, Thammasat University, Rangsit Campus, Klong Luang District, Pathumtani, Thailand; Mae-Sot General Hospital, Mae-Sot, Tak Province, Thailand.

出版信息

Am J Trop Med Hyg. 2011 Sep;85(3):568-72. doi: 10.4269/ajtmh.2011.11-0194.

DOI:10.4269/ajtmh.2011.11-0194
PMID:21896824
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3163886/
Abstract

The aim of this study was to investigate the association between genetic polymorphisms of Plasmodium falciparum chloroquine resistance transporter (pfcrt), P. falciparum multidrug resistance 1 (pfmdr1), and P. falciparum ATPase (pfatp6) and clinical outcome after a three-day mefloquine-artesunate combination therapy in 134 patients with uncomplicated Plasmodium falciparum malaria in an area with multidrug resistance along the Thailand-Myanmar border. Analysis of gene mutation and amplification were performed by nested real-time polymerase chain reaction and SYBR Green I real-time polymerase chain reaction, respectively. The mutation for pfcrt (codons 76, 220, 271, 326, 356, and 371) was found in all isolates (100%), whereas no mutation of pfmdr1 (codon 86) and pfatp6 (codons 37, 693, 769, 898) was found. The Pfmdr1 copy number was significantly higher in isolates with recrudescence (median number = 2.44) compared with a sensitive response (median number = 1.44). The gene copy number was also found to be significantly higher in paired isolates collected before treatment and at the time of recrudescence. All isolates carried one pfatp6 gene copy.

摘要

本研究旨在调查在泰国-缅甸边境地区多药耐药区 134 例无并发症恶性疟原虫感染患者中,疟原虫氯喹耐药转运蛋白(pfcrt)、疟原虫多药耐药 1 基因(pfmdr1)和疟原虫 ATP 酶(pfatp6)的基因多态性与 3 天甲氟喹-青蒿琥酯联合治疗临床结局的相关性。通过巢式实时聚合酶链反应和 SYBR Green I 实时聚合酶链反应分别进行基因突变和扩增分析。所有分离株均发现 pfcrt(密码子 76、220、271、326、356 和 371)发生突变(100%),而 pfmdr1(密码子 86)和 pfatp6(密码子 37、693、769、898)未发生突变。复发组 Pfmdr1 拷贝数(中位数=2.44)明显高于敏感反应组(中位数=1.44)。在治疗前和复发时采集的配对分离株中,基因拷贝数也明显更高。所有分离株均携带一个 pfatp6 基因拷贝。

相似文献

1
Polymorphisms of molecular markers of antimalarial drug resistance and relationship with artesunate-mefloquine combination therapy in patients with uncomplicated Plasmodium falciparum malaria in Thailand.泰国无并发症恶性疟原虫疟疾患者的抗疟药物耐药性分子标记物多态性与青蒿琥酯-甲氟喹联合治疗的关系。
Am J Trop Med Hyg. 2011 Sep;85(3):568-72. doi: 10.4269/ajtmh.2011.11-0194.
2
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.恶性疟原虫对甲氟喹的耐药性及 pfmdr1 基因拷贝数增加。
Lancet. 2004;364(9432):438-447. doi: 10.1016/S0140-6736(04)16767-6.
3
Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity.在泰缅边境地区鉴定恶性疟原虫对青蒿琥酯-甲氟喹联合用药的耐药性:临床寄生虫学反应、全身药物暴露和体外寄生虫敏感性的综合分析。
Malar J. 2013 Jul 30;12:263. doi: 10.1186/1475-2875-12-263.
4
Genetic polymorphisms of candidate markers and in vitro susceptibility of Plasmodium falciparum isolates from Thai-Myanmar border in relation to clinical response to artesunate-mefloquine combination.来自泰国-缅甸边境的恶性疟原虫分离株候选标记的基因多态性及其体外药敏性与青蒿琥酯-甲氟喹联合用药临床反应的关系。
Acta Trop. 2014 Nov;139:77-83. doi: 10.1016/j.actatropica.2014.06.015. Epub 2014 Jul 5.
5
Therapeutic efficacy of artesunate in the treatment of uncomplicated Plasmodium falciparum malaria and anti-malarial, drug-resistance marker polymorphisms in populations near the China-Myanmar border.青蒿琥酯治疗无并发症恶性疟原虫疟疾的疗效及中缅边境地区人群的抗疟药物耐药性标志物多态性。
Malar J. 2012 Aug 16;11:278. doi: 10.1186/1475-2875-11-278.
6
Molecular analysis of pfatp6 and pfmdr1 polymorphisms and their association with in vitro sensitivity in Plasmodium falciparum isolates from the Thai-Myanmar border.来自泰缅边境的恶性疟原虫分离株中 pfATP6 和 pfmdr1 多态性的分子分析及其与体外敏感性的关系。
Acta Trop. 2011 Oct-Nov;120(1-2):130-5. doi: 10.1016/j.actatropica.2011.07.003. Epub 2011 Jul 13.
7
Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.柬埔寨恶性疟原虫中Pfmdr1基因拷贝数与青蒿素衍生物联合疗法失败情况
Malar J. 2009 Jan 12;8:11. doi: 10.1186/1475-2875-8-11.
8
Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.青蒿琥酯-甲氟喹联合疗法治疗柬埔寨南部非复杂性恶性疟原虫疟疾失败。
Malar J. 2009 Jan 12;8:10. doi: 10.1186/1475-2875-8-10.
9
Distribution patterns of molecular markers of antimalarial drug resistance in Plasmodium falciparum isolates on the Thai-Myanmar border during the periods of 1993-1998 and 2002-2008.1993 - 1998年及2002 - 2008年期间泰国-缅甸边境恶性疟原虫分离株中抗疟药耐药分子标记的分布模式
BMC Genomics. 2024 Mar 11;25(1):269. doi: 10.1186/s12864-023-09814-3.
10
Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border.在泰缅边境的一个多药耐药地区,青蒿琥酯-甲氟喹三联疗法三天疗程的疗效下降。
Malar J. 2010 Oct 8;9:273. doi: 10.1186/1475-2875-9-273.

引用本文的文献

1
Influence of genetic factors of humans, mosquitoes and parasites, on the evolution of Plasmodium falciparum infections, malaria transmission and genetic control methods: a review of the literature.人类、蚊子和寄生虫的遗传因素对恶性疟原虫感染的演变、疟疾传播及遗传控制方法的影响:文献综述
BMC Med Genomics. 2025 Jun 2;18(1):100. doi: 10.1186/s12920-025-02165-w.
2
Distribution patterns of molecular markers of antimalarial drug resistance in Plasmodium falciparum isolates on the Thai-Myanmar border during the periods of 1993-1998 and 2002-2008.1993 - 1998年及2002 - 2008年期间泰国-缅甸边境恶性疟原虫分离株中抗疟药耐药分子标记的分布模式
BMC Genomics. 2024 Mar 11;25(1):269. doi: 10.1186/s12864-023-09814-3.
3
Assessing the Roles of Molecular Markers of Antimalarial Drug Resistance and the Host Pharmacogenetics in Drug-Resistant Malaria.评估抗疟药物耐药性分子标志物和宿主药物遗传学在耐药疟疾中的作用
J Trop Med. 2022 May 17;2022:3492696. doi: 10.1155/2022/3492696. eCollection 2022.
4
K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.缅甸恶性疟原虫疟疾中K13突变和pfmdr1拷贝数变异
Malar J. 2016 Feb 24;15:110. doi: 10.1186/s12936-016-1147-3.
5
Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya.肯尼亚西部接受蒿甲醚-本芴醇治疗前和治疗后疟原虫中,恶性疟原虫分子标记物流行率的时间趋势。
Int J Parasitol Drugs Drug Resist. 2015 Jun 29;5(3):92-9. doi: 10.1016/j.ijpddr.2015.05.005. eCollection 2015 Dec.
6
Antimalarial drug resistance in Africa: key lessons for the future.非洲的抗疟药耐药性:未来的关键经验教训。
Ann N Y Acad Sci. 2015 Apr;1342:62-7. doi: 10.1111/nyas.12766.
7
Polymorphic patterns of pfcrt and pfmdr1 in Plasmodium falciparum isolates along the Thai-Myanmar border.泰国-缅甸边境恶性疟原虫分离株中pfcrt和pfmdr1的多态性模式
Asian Pac J Trop Biomed. 2013 Dec;3(12):931-5. doi: 10.1016/S2221-1691(13)60181-1.
8
Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity.在泰缅边境地区鉴定恶性疟原虫对青蒿琥酯-甲氟喹联合用药的耐药性:临床寄生虫学反应、全身药物暴露和体外寄生虫敏感性的综合分析。
Malar J. 2013 Jul 30;12:263. doi: 10.1186/1475-2875-12-263.
9
Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studies.缅甸三国交界地区临床和亚临床人群中耐药恶性疟原虫的分子监测:耐药性研究的横断面数据和系统评价。
Malar J. 2012 Sep 19;11:333. doi: 10.1186/1475-2875-11-333.

本文引用的文献

1
Drug-Resistant Malaria: The Era of ACT.抗药性疟疾:ACT 时代。
Curr Infect Dis Rep. 2010 May;12(3):165-73. doi: 10.1007/s11908-010-0099-y.
2
Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.巴基斯坦南部地区疟原虫现场分离株中与耐药性相关的多态性的流行情况。
Malar J. 2011 Jan 28;10:18. doi: 10.1186/1475-2875-10-18.
3
Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border.在泰缅边境的一个多药耐药地区,青蒿琥酯-甲氟喹三联疗法三天疗程的疗效下降。
Malar J. 2010 Oct 8;9:273. doi: 10.1186/1475-2875-9-273.
4
pfmdr1 amplification associated with clinical resistance to mefloquine in West Africa: implications for efficacy of artemisinin combination therapies.pfmdr1 扩增与西非地区对甲氟喹的临床耐药性相关:对青蒿素联合疗法疗效的影响。
J Clin Microbiol. 2010 Oct;48(10):3797-9. doi: 10.1128/JCM.01057-10. Epub 2010 Jul 28.
5
Experimental evolution of resistance to artemisinin combination therapy results in amplification of the mdr1 gene in a rodent malaria parasite.抗青蒿素联合疗法的实验进化导致啮齿动物疟原虫中 mdr1 基因的扩增。
PLoS One. 2010 Jul 15;5(7):e11593. doi: 10.1371/journal.pone.0011593.
6
The patterns of mutation and amplification of Plasmodium falciparum pfcrt and pfmdr1 genes in Thailand during the year 1988 to 2003.1988 年至 2003 年期间,泰国疟原虫 falciparum pfcrt 和 pfmdr1 基因的突变和扩增模式。
Parasitol Res. 2010 Aug;107(3):539-45. doi: 10.1007/s00436-010-1887-x. Epub 2010 May 7.
7
Analysis of gene mutations involved in chloroquine resistance in Plasmodium falciparum parasites isolated from patients in the southwest of Saudi Arabia.对从沙特阿拉伯西南部患者分离出的恶性疟原虫中与氯喹耐药性相关的基因突变进行分析。
Ann Saudi Med. 2010 May-Jun;30(3):187-92. doi: 10.4103/0256-4947.62826.
8
Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum.探讨候选基因对恶性疟原虫青蒿素耐药性的贡献。
Antimicrob Agents Chemother. 2010 Jul;54(7):2886-92. doi: 10.1128/AAC.00032-10. Epub 2010 Apr 26.
9
Multiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in Cambodia.柬埔寨恶性疟原虫多药耐药基因(pfmdr1)扩增的多种遗传背景和 184F 突变的选择清除。
J Infect Dis. 2010 May 15;201(10):1551-60. doi: 10.1086/651949.
10
pfmdr1 amplification and fixation of pfcrt chloroquine resistance alleles in Plasmodium falciparum in Venezuela.委内瑞拉恶性疟原虫 pfmdr1 扩增与 pfcrt 氯喹耐药等位基因固定。
Antimicrob Agents Chemother. 2010 Apr;54(4):1572-9. doi: 10.1128/AAC.01243-09. Epub 2010 Feb 9.